Video

Urology residency program director discusses preference signaling process

Author(s):

Urology Times staff
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Moben Mirza, MD, FACS, Residency Program Director and Professor, Department of Urology, University of Kansas, discusses the use of the preference signaling initiative as part of the overall urology residency matching process.

      Related Videos
      Jill M. Hamilton-Reeves, PhD, RD, CSO, answers a question during a Zoom video interview
      Dr. Hamilton-Reeves on the role of diet and exercise in patients with prostate cancer
      blur image background of corridor in hospital or clinic image | Image Credit: © whyframeshot - stock.adobe.com
      Weight management appears to improve quality of life in patients with prostate cancer
      Jill M. Hamilton Reeves, PhD, RD, CSO, answers a question during a Zoom video interview
      Dr. Hamilton-Reeves discusses weight management in patients with prostate cancer
      Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
      Experts investigate weight management and prostate cancer progression
      How to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgery
      How to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgery
      mentor teaching two medical students
      Dr. Litwin describes the challenges to a successful mentor/mentee relationship in urology
      young female doctor standing in front of medical staff
      Expert provides insight as to what makes a successful mentee
      Dr. Litwin in an interview with Urology Times
      Dr. Litwin shares ways to be an effective mentor
      Dr. Harris shares advice for urologists starting a career in community practice
      Dr. Harris shares advice for urologists starting a career in community practice
      Optimizing the number of urology residency applications
      Optimizing the number of urology residency applications
      Related Content
      Weight scale | Image Credit: © Win Nondakowit - stock.adobe.com
      June 12th 2024

      Study evaluates weight management and prostate cancer progression, QOL

      Urology Times staff
      "To me, the most compelling outcome is really the quality-of-life outcomes. General quality of life as well as emotional quality of life improved in the intervention group significantly," says Jill M. Hamilton Reeves, PhD, RD, CSO.
      Dr. Bristol Whiles discusses her experience as a urology resident
      July 25th 2022

      Dr. Bristol Whiles discusses her experience as a urology resident

      Kansas University Department of Urology
      On this podcast, Bristol Whiles, MD, discusses her urology residency experience at the Kansas University School of Medicine Department of Urology.
      stethoscope sitting on a stack of books
      March 24th 2023

      Small urology programs saw increase in at-home, in-section matches during COVID-19 pandemic

      Hannah Clarke
      In 2021, small urology programs had 28.1% spots filled by applicants at their home program, compared with 16.2% between 2016 and 2020.
      Applications now open for Prospect: A paid summer medical student research fellowship in urology
      December 16th 2022

      Applications now open for Prospect: A paid summer medical student research fellowship in urology

      Hannah Clarke
      The clinical research program seeks to increase the number of URiM medical students entering the field of urology.
      zephyr_p - stock.adobe.com
      September 22nd 2022

      Asked by a Resident: Dr. Efe Chantal Ghanney Simons interviews Dr. Mark S. Litwin

      Janelle Hart
      "The most important thing I feel I've learned in my life so far is the value of human interaction and human connection," says Mark S. Litwin, MD, MPH.
      PSMA-PET imaging disrupts prostate cancer paradigm
      September 20th 2022

      PSMA-PET imaging disrupts prostate cancer paradigm

      Jason M. Broderick
      In this interview, William P. Parker, MD, highlights the development of PSMA-PET imaging in prostate cancer, FDA-approved PSMA-PET agents, and the next steps with this disruptive technique.
      © 2025 MJH Life Sciences

      All rights reserved.